Option chain shows key data for Klotho Neurosciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Klotho Neurosciences.

Klotho Neurosciences (NASDAQ:KLTO) Stock, Option Chain

Klotho Neurosciences

Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.

iPad's Impact On Apple

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AAPL

AVNW

BHIL

CIFR

CYCN

DECK

DGNX

ENVB

EVTV

KITT

KLTO

ORKT

SLNG

TDTH

TEAM

Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

movers image

ATNF

BREA

CLMT

CTCX

EFSH

GEVO

GRTS

LCID

MTEM

PRQR

QNRX

SAIH

STAF

STEC

VINE

VSME

Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

BLMZ

CETX

CNEY

CRKN

JTAI

MNTS

MRSN

NMHI

PETZ

SPGC

TVGN

WHLR

Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences Inc

Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) has outperformed the market over the past 5 years by 9.0% on an annualized basis producing an average annual return of 21.84%. Currently, Raymond James Finl has a market capitalization of $34.47 billion. 
Buying $100 In RJF: If an investor had bought $100 of RJF stock 5 years ago, it would be worth $274.82 today based on a price of $168.48 for RJF at the time of writing.
<h3>Raymond James Finl's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738359909_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Raymond James Finl Stock In The Last 5 Years

SR Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRBK#NASDAQ">SRBK</a>) reported quarterly earnings of $0.12 per share. This is a 33.33 percent decrease over earnings of $0.18 per share from the same period last year.

Earnings

SRBK

SR Bancorp Q4 EPS $0.12 Down From $0.18 YoY

It took only four sessions for the U.S. stock market to recover most of the losses triggered earlier in the week after the Chinese startup DeepSeek launched a more efficient and cost-effective AI platform than OpenAI&#8216;sChatGPT, sparking a sharp <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43239042/magnificent-seven-broadcom-lose-nearly-900-billion-in-value-as-deepseek-sparks-ai-carnage-why-this-expert-is-still-bullish-on-us-tech">selloff on Wall Street.</a>
Investors began questioning the need to allocate capital to higher-cost AI-related companies, sending shares of top chipmakers and data <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43267966/deepseeks-low-cost-model-reshapes-ai-landscape-experts-predict-shift-to-application-layer">centers into a tailspin.</a>
Yet resilient quarterly earnings reports and a significantly less hawkish Federal Reserve Chair Jerome Powell compared to his stance in December gave bulls the confidence to buy the dip.
As widely expected, the Federal Reserve left interest rates <a href="https://www.benzinga.com/25/01/43316048/fed-holds-interest-rates-steady-halts-streak-of-consecutive-cuts-as-inflation-remains-elevated">unchanged at 4.25%–4.5%.</a> Surprisingly, Powell instilled greater hopes for potential rate cuts in the future, stating that monetary <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43318325/a-different-powell-emerges-fed-chair-softens-hawkish-tone-on-interest-rates-bitcoin">policy remains "meaningfully restrictive."</a>
The scars remained visible for Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), which lost about 15% in a week, with the chipmaker falling again on Friday following reports that U.S. plans to levy a 10% tariff on China.
Risk sentiment deteriorated during Friday afternoon trading in New York amid escalating tariff concerns.
President Donald Trump said again he plans to introduce 25% tariffs on imports from Mexico and Canada, though reports differed on when it would go into effect. 
On Friday, White House press secretary Karoline Leavitt said tariffs are coming Saturday.
&#8220;The President will implement 25% [tariffs] on Mexico, Canada and 10% on China,&#8221; Leavitt stated. 
Analysts warn that such a measure could cause significant economic disruptions in North America, with the U.S. automotive industry<a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43398182/trumps-25-tariffs-could-slaughter-canada-mexico-economies-hit-us-auto-industry-analysts-warn"> among the most affected.</a>
Cruise liners were among the best performers in the S&amp;P 500 for the week, with Royal Caribbean Cruise Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>), Norwegian Cruise Line Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) and Carnival Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) all posting double-digit percentage gains following strong <a href="https://www.benzinga.com/general/travel/25/01/43312480/royal-caribbean-cruises-posts-q4-beat-a-compelling-long-term-strategy-says-analyst">earnings from Royal Caribbean.</a>
United Parcel Service Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) was one of the worst laggards, plunging about 15% — its worst week since September 2008 — after the parcel service agreed with Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) to phase out more than 50% of the e-commerce giant&#8217;s volume by <a href="https://www.benzinga.com/25/01/43389661/these-analysts-cut-their-forecasts-on-ups-following-q4-earnings">the second half of 2026.</a>
You might have missed…
<h3 class="wp-block-heading">Microsoft AI Strength</h3>
Wall Street analysts assessed Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>)'s quarterly results, weighing Azure's slowing growth against its AI-driven potential. Despite cloud challenges, analysts said Microsoft remains a compelling investment due to its strategic <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43351098/microsoft-analysts-weigh-azure-weakness-against-ai-strength-most-compelling-investment-opportunities">advancements in artificial intelligence.</a>
<h3 class="wp-block-heading">Musk Wins Back Advertisers</h3>
Amazon.com is increasing its ad spending on X, reversing previous cuts. Apple Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NYSE">AAPL</a>) is also considering resuming ads on the platform, signaling a potential recovery in advertiser confidence <a href="https://www.benzinga.com/general/social-media/25/01/43373012/elon-musk-bringing-advertisers-back-to-x-amazon-boosts-spending-apple-considers-return">under Elon Musk's leadership.</a>
<h3 class="wp-block-heading">GM Earnings Beat</h3>
General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) exceeded earnings expectations last quarter, posting strong revenue growth. Yet the company incurred over $5 billion in charges after halting funding for its Cruise robotaxi business and <a href="https://www.benzinga.com/25/01/43263700/general-motors-stock-gains-after-q4-earnings-beat-incurs-charges-from-funding-halt-of-cruise-robotaxi-business">restructuring operations in China</a>. Analysts remain optimistic about GM&#8217;s long-term <a href="https://www.benzinga.com/25/01/43315953/general-motors-turnaround-on-track-despite-ev-roadblocks-analysts-view">growth and turnaround potential.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/01/43354861/vanguards-voo-set-to-overtake-spy-as-worlds-largest-etf-after-record-january-inflows">Vanguard&#8217;s VOO Set To Overtake SPY As World&#8217;s Largest ETF After Record January Inflows</a></li>
</ul>

Analyst Color

Equities

Government

Large Cap

Regulations

Econ #s

Federal Reserve

Tech

AMZN

MSFT

NCLH

NVDA

Stocks Trim DeepSeek Losses, Fed Holds Steady, Trump Slaps 25% Tariffs On Canada, Mexico: This Week In The Markets

The earnings results for Territorial Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBNK#NASDAQ">TBNK</a>) for Q4 were made public on Friday, January 31, 2025 at 04:30 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
Territorial Bancorp missed estimated earnings by -150.0%, reporting an EPS of $-0.2 versus an estimate of $-0.08.
Revenue was up $7.94 billion from the same period last year.
<h3>Analysis of Past Earnings</h3>
The company missed on EPS by $0.1 in the previous quarter, leading to a 2.0% increase share price change the next day.
Here's a look at Territorial Bancorp's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.05</td>
<td>-0.03</td>
<td>0.02</td>
<td>0.06</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.15</td>
<td>-0.09</td>
<td>-0.06</td>
<td>0.04</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>8.10M</td>
<td>9.03M</td>
<td>9.88M</td>
<td>10.25M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>8.10M</td>
<td>8.90M</td>
<td>9.35M</td>
<td>10.02M</td>
</tr>
</tbody>
</table>

 Listen to the earnings announcement yourself by <a href="">clicking here</a>. 
To track all earnings releases for Territorial Bancorp <a href="https://www.benzinga.com/quote/TBNK/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TBNK

Earnings Breakdown: Territorial Bancorp Q4

Spirit AeroSystems Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPR#NYSE">SPR</a>) today announced that, at the special meeting of its shareholders held earlier today, its shareholders voted to approve the proposed acquisition of Spirit AeroSystems by The Boeing Company. The transaction, <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4352793-1&amp;h=764042815&amp;u=https%3A%2F%2Fwww.spiritaero.com%2Fpages%2Frelease%2Fspirit-aerosystems-announces-acquisition-by-boeing-in-8.3-billion-transaction%2F&amp;a=announced+last+summer">announced last summer</a>, is expected to close in mid-2025, subject to closing conditions including the receipt of regulatory approvals.

Spirit AeroSystems Shareholders Approve Acquisition By Boeing; Expected To Close In Mid-2025

Territorial Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBNK#NASDAQ">TBNK</a>) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.08) by 150 percent. This is a 600 percent decrease over earnings of $0.04 per share from the same period last year.

Earnings Misses

Territorial Bancorp Q4 EPS $(0.20) Misses $(0.08) Estimate

Affinity Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFBI#NASDAQ">AFBI</a>) reported quarterly earnings of $0.20 per share. This is a 13.04 percent decrease over earnings of $0.23 per share from the same period last year.

AFBI

Affinity Bancshares Q4 EPS $0.20 Down From $0.23 YoY

ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) has outperformed the market over the past 10 years by 18.63% on an annualized basis producing an average annual return of 29.94%. Currently, ServiceNow has a market capitalization of $210.00 billion. 
Buying $1000 In NOW: If an investor had bought $1000 of NOW stock 10 years ago, it would be worth $13,649.38 today based on a price of $1017.02 for NOW at the time of writing.
<h3>ServiceNow's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738359009_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

The U.S. Food and Drug Administration <a href="https://in.benzinga.com/trading-ideas/movers/25/01/43395856/vertex-pharmaceuticals-shares-are-up-today-whats-going-on">approved</a> the first new pain reliever to hit the market in over 20 years. This medication, produced by Vertex Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>), is a non-opioid and therefore non-addictive. The new drug, suzetrigine, will be sold under the brand name Journavx.
Unlike opioids, Journavx blocks pain signals in the peripheral nervous system, not in the brain, so it does not create the same pleasurable effects usually felt with opioids and which often leads to dependence or addiction.
"A new non-opioid analgesic therapeutic class for acute pain offers an opportunity to mitigate certain risks associated with using an opioid for pain and provides patients with another treatment option," Dr. Jacqueline Corrigan-Curay, acting director of the FDA's Center for Drug Evaluation and Research, <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-novel-non-opioid-treatment-moderate-severe-acute-pain">said</a> in a press release. "This action and the agency's designations to expedite the drug's development and review underscore FDA's commitment to approving safe and effective alternatives to opioids for pain management."
Now Read: <a href="http://Purdue Pharma, Sackler Family To Pay $7.4 Billion In Settlement Over OxyContin That Fueled 'Devastating' Opioid Epidemic">Purdue Pharma, Sackler Family To Pay $7.4 Billion In Settlement Over OxyContin That Fueled &#8216;Devastating&#8217; Opioid Epidemic</a>
Government surveys show analgesics, or medications that control pain, are the most commonly prescribed type of drug in hospitals. And, <a href="https://www.cdc.gov/nchs/products/databriefs/db491.htm">according</a> to the Centers for Disease Control drug overdoses related to opioids, including Fentanyl are among the leading causes of accidental death in the U.S.  
Approximately 125 million opioid prescriptions were dispensed&nbsp;to American patients in 2023 to treat moderate to severe pain, <a href="https://www.cdc.gov/overdose-prevention/about/prescription-opioids.html#:~:text=Approximately%20125%20million%20opioid%20prescriptions,dose%20in%20the%20smallest%20quantity.">according</a> to the CDC. 
Meanwhile, <a href="https://www.benzinga.com/topic/medical-cannabis">medical marijuana</a> has been doing its part to help treat pain safely and effectively.
<h1 class="wp-block-heading">Large Study Provides New Insights: It&#8217;s About The Side-Effects</h1>
One of the <a href="https://www.benzinga.com/markets/cannabis/24/01/36578723/huge-study-reveals-cannabis-provides-similar-pain-relief-benefits-as-opioids-without-negative-co">largest studies to date</a>, which viewed 90 randomized controlled trials involving 22,028 participants, weighed the pain-alleviating potential of&nbsp;<a href="https://www.benzinga.com/cannabis" target="_blank" rel="noreferrer noopener">medical marijuana</a>&nbsp;versus opioids. The study was undertaken by the Canadian Institutes of Health Research&nbsp;and&nbsp;Health Canada. 
The <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10773353/" target="_blank" rel="noreferrer noopener">research</a> showed opioids and medical marijuana both offer moderate improvements in pain intensity for the treatment of non-cancer pain, which impacts 20% of people around the world and is generally treated with opioids.
The difference is in the side effects. Participants using medical marijuana were found to be far less likely to abandon treatment due to adverse effects as compared to those using opioids. That, in addition to the fact cannabis does not cause respiratory depression which can result from opioid consumption. Marijuana is also not considered to be physically addictive although <a href="https://drugabuse.com/blog/marijuana-addiction/">research contends</a> that regular as well as heavy consumers can develop a psychological dependence on marijuana depending on the individual.
Whereas with opioids, "Anyone taking prescription opioids is at risk for unintentional overdose or death and can become addicted regardless of race, gender, income level, or social class," <a href="https://www.cdc.gov/overdose-prevention/about/prescription-opioids.html#:~:text=Approximately%20125%20million%20opioid%20prescriptions,dose%20in%20the%20smallest%20quantity.">noted</a> the CDC.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/01/43403416/is-big-pharma-about-to-win-goldman-sachs-weighs-in-on-340b-and-medicaid-shifts">Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts</a></li>
</ul>
Photo: Shutterstock

Cannabis

Health Care

VRTX

FDA Approves First Non-Opioid Pain Pill, As Medical Marijuana Remains A Proven Alternative For Relief

Pathfinder Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBHC#NASDAQ">PBHC</a>) reported quarterly earnings of $0.69 per share. This is a 68.29 percent increase over earnings of $0.41 per share from the same period last year.

PBHC

Pathfinder Bancorp Q4 EPS $0.69 Up From $0.41 YoY

The&nbsp;J.M. Smucker Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJM#NYSE">SJM</a>) announced today it has reached a definitive agreement to divest its Cloverhill and Big Texas&nbsp;brands, as well as certain private label products, to JTM Foods, LLC (JTM). The all-cash transaction is valued at approximately $40 million, subject to a working capital adjustment, and includes relevant trademarks and licenses and the Company's manufacturing facility in Chicago, Illinois. Approximately 400 employees will also transition with the business.

Contracts

Asset Sales

J.M. Smucker Announces $40M Divestment Of Cloverhill, Big Texas Brands To JTM Foods; 400 Employees To Transition With The Business

Fluor Corporation Announces That Its Mining & Metals Business Was Awarded A Joint Venture Contract With Hatch To Perform Engineering, Procurement And Construction Management) for BHP's Proposed Olympic Dam Smelter & Refinery Expansion Project in South Australia

Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) has outperformed the market over the past 5 years by 16.6% on an annualized basis producing an average annual return of 29.44%. Currently, Apollo Global Management has a market capitalization of $96.74 billion. 
Buying $100 In APO: If an investor had bought $100 of APO stock 5 years ago, it would be worth $372.18 today based on a price of $170.98 for APO at the time of writing.
<h3>Apollo Global Management's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738358111_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Apollo Global Management 5 Years Ago Would Be Worth This Much Today

Blue Hat Interactive Entertainment Technology ("Blue Hat" or the "Company") (NASDAQ:<a href="https://www.benzinga.com/stock/BHAT#NASDAQ">BHAT</a>)&nbsp;today announced the completion of its purchase of one ton of gold, pursuant to sales agreement dated October, 2023, with Rongxin Precious Metal Technology Co., Ltd ("Rongxin"). The transaction was finalized following the Company's settlement of the remaining balance through the issuance of ordinary shares.
Showcasing the Effectiveness of the Company's Strategic Positioning
Blue Hat has made a number of strategic moves over the past two years as part of its transition to focus gold and supply chain businesses:
<ul>
<li>Driving business development: In March 2024, the Company announced its strategic shift to become an AI-driven financial services enterprise, focusing on the development of gold trading and commodity-related businesses.</li>
<li>Fostering strategic alliance: In May 2024, the Company entered into letter of intent for a potential acquisition with GTC Multi Trading DMCC, further expanding its presence in the global commodity trading sector.</li>
<li>Platform development: At the end of May 2024, Mr. Chen Xiaodong, chief executive officer of Blue Hat, unveiled a plan to build an intelligent gold trading platform using technological innovation to enhance the transparency and efficiency of gold trading.</li>
<li>Achieving regulatory milestones: In June 2024, the Company's subsidiary successfully qualified as Category A Dealer in Precious Metals and Stones, which provides a critical foundation for the Company's long-term development of its gold and commodities business.</li>
</ul>
Notably, the gold purchase agreement with Rongxin was executed and completed at a price of RMB 473.70 per gram (about US$1,900 per ounce), which presents significant cost advantage. As the gold delivery price surpassed US$2,780 per ounce at the beginning of 2025, the Company's book assets have appreciated by nearly US$25 million, underscoring the foresight of Blue Hat's management in investment and strategic positioning.

BHAT

Blue Hat Completes Purchase Of One Ton Gold From Rongxin Previously Announced In October 2023, Boosting Assets By ~$25M Amid Strategic Shift To AI-Driven Financial Services

FutureFuel Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FF#NYSE">FF</a>) ("FutureFuel" or the "Company"), a manufacturer of custom and performance chemicals and biofuels, today announced certain matters with respect to its Biodiesel production.
FutureFuel initiated its scheduled annual maintenance and turnaround of its Biodiesel plant at the end of December 2024. This turnaround has proven more extensive than expected. Therefore, the Company currently believes the turnaround will continue through February 2025. Biodiesel production will not commence until this turnaround is complete.

FutureFuel Announces Extended Biodiesel Plant Maintenance, Production Delayed Until February 2025

Dividends

CINF

Cincinnati Financial Corporation Announces An $0.87 Per Share Regular Quarterly Cash Dividend, Increasing By 7% From The Previous $0.81

VOXX

VOXX International Received Nasdaq Notice Regarding Delayed Filing Of Quarterly Report On Form 10-Q

Cryptocurrency markets are under pressure on Friday after President <a href="https://www.benzinga.com/government/regulations/25/01/43403052/wall-street-sinks-on-trumps-tariff-announcement-bitcoin-drops-3-dollar-soars">Trump's tariff announcement</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td> $101,924.10</td>
<td>-3.6%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td> $3,310.99</td>
<td>+1.5%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td> $228.96</td>
<td>-4.7%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td> $3.01</td>
<td>-4.2%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td> $0.3245</td>
<td>-3.1%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td> $0.0000187</td>
<td>-0.6%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume decreasing by 3.6% and daily active addresses growing by 4.3%. Transactions greater than $100,000 are up from 10,871 to 12,089 in a single day. Exchanges netflows are down by 1,118.7%.</li>
<li>Coinglass data reports 102,855 traders were liquidated in the past 24 hours for $253.97 million.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/01/43399688/microstrategy-prices-preferred-stock-offering-at-80-per-share-seeks-563m-to-buy-bitcoin">MicroStrategy Prices Preferred Stock Offering At $80 Per Share, Seeks $563M To Buy Bitcoin</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43396466/grayscale-introduces-dogecoin-trust-for-institutional-investors">Grayscale Introduces Dogecoin Trust For Institutional Investors</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43393680/elon-musks-father-launches-musk-it-meme-coin-to-fund-new-think-tank">Elon Musk&#8217;s Father Launches &#8216;Musk It&#8217; Meme Coin To Fund New Think Tank</a></li>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/01/43391374/anthony-pompliano-countries-secretly-accumulating-bitcoin-2025-could-be-fun">Anthony Pompliano: Countries Secretly Accumulating Bitcoin, 2025 Could Be &#8216;Fun&#8217;</a></li>
</ul>
Top Losers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Fartcoin (CRYPTO: FARTCOIN)</td>
<td>&nbsp;$0.9181&nbsp;</td>
<td>-23.5%</td>
</tr>
<tr>
<td>SPX6900 (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">SPX</a>)</td>
<td>&nbsp;$1.21 </td>
<td>-8.2%</td>
</tr>
<tr>
<td>Onyxoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">XCN</a>)</td>
<td>$0.03264</td>
<td>-7.8%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With Bitcoin prices dropping, crypto trader Altcoin Sherpa predicts that one &#8220;god candle&#8221; is needed for Bitcoin to reverse its decline. 
Meanwhile, Ansem <a href="https://x.com/blknoiz06/status/1885415970996363267">cautioned</a> traders after Bitcoin faced rejection from range highs.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">1 God Candle is all we need for <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> <a href="https://t.co/XfekNmoCYC">pic.twitter.com/XfekNmoCYC</a>
&mdash; Altcoin Sherpa (@AltcoinSherpa) <a href="https://twitter.com/AltcoinSherpa/status/1885360834253066260?ref_src=twsrc%5Etfw">January 31, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
More Crypto Online <a href="https://x.com/Morecryptoonl/status/1885401765463441799">explained</a> that Bitcoin remains in a wave 4 support zone, with the $101,729 level acting as a key support—losing this level could signal a deeper pullback.
Glassnode <a href="https://x.com/glassnode/status/1885349824146661607">data</a> shows that Bitcoin has formed a strong supply cluster around $98,000 after 45 days of high-volume trading in the $94,000–$101,000 range, reinforcing this zone as a critical support in corrections and resistance in rallies.
Rekt Capital pointed out that Bitcoin might be retesting a post-breakout structure, with a daily close above the diagonal confirming strength, while failure could send prices back to the $101,000 range low.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/BTC?src=hash&amp;ref_src=twsrc%5Etfw">#BTC</a> Could Bitcoin be pulling back for a post-breakout retest of the light blue triangular structure? Needs a Daily Close above the light blue diagonal to confirm a successful retest A failure would see price drop back into the Range Low of $101k <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> <a href="https://twitter.com/hashtag/Crypto?src=hash&amp;ref_src=twsrc%5Etfw">#Crypto</a> <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://t.co/RlWTEpbQ52">https://t.co/RlWTEpbQ52</a> <a href="https://t.co/GMHv5QRohY">pic.twitter.com/GMHv5QRohY</a>
&mdash; Rekt Capital (@rektcapital) <a href="https://twitter.com/rektcapital/status/1885398486914408921?ref_src=twsrc%5Etfw">January 31, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43402767/bitcoin-cycle-is-a-thing-of-the-past-this-time-its-different-expert-says">Bitcoin Cycle Is A Thing Of The Past, This Time It's Different, Expert Says</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SHIB

$SOL

$SPX

$XCN

$XRP

Bitcoin, XRP, Dogecoin Pull Back On Trump Tariff Announcement, Ethereum Hanging On

<h3>Gainers</h3>
<ul>
<li>TCTM Kids IT Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCTM#NASDAQ">TCTM</a>) shares moved upwards by 118.1% to $0.4 during Friday's pre-market session. The market value of their outstanding shares is at $3.8 million. </li>
<li>Algorhythm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) shares increased by 25.81% to $0.03. The market value of their outstanding shares is at $2.8 million. </li>
<li>LightInTheBox Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LITB#NYSE">LITB</a>) shares rose 20.38% to $1.24. The company's market cap stands at $137.8 million. </li>
<li>China Liberal Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLEU#NASDAQ">CLEU</a>) stock rose 20.24% to $0.18. The market value of their outstanding shares is at $47.9 million. </li>
<li>Jiuzi Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZXN#NASDAQ">JZXN</a>) stock increased by 13.88% to $2.05. The market value of their outstanding shares is at $18.5 million. </li>
<li>Venu Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VENU#AMEX">VENU</a>) stock rose 9.18% to $10.7. The company's market cap stands at $404.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Latham Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) stock decreased by 19.7% to $6.01 during Friday's pre-market session. The market value of their outstanding shares is at $694.9 million. </li>
<li>Beazer Homes USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BZH#NYSE">BZH</a>) stock fell 13.07% to $24.08. The company's market cap stands at $751.3 million. The company's, Q1 earnings came out yesterday. </li>
<li>Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) shares declined by 12.61% to $194.98. The market value of their outstanding shares is at $29.6 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Sacks Parente Golf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) shares fell 12.36% to $0.79. The market value of their outstanding shares is at $6.9 million. </li>
<li>Zapp Electric Vehicles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) shares fell 11.35% to $1.25. The company's market cap stands at $5.2 million. The company's, FY earnings came out today. </li>
<li>Gentex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNTX#NASDAQ">GNTX</a>) stock declined by 11.27% to $25.04. The company's market cap stands at $5.6 billion. As per the news, the Q4 earnings report came out today. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLEU

GNTX

JZXN

LITB

RIME

SWIM

TCTM

VENU

ZAPP

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Cyclerion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) stock moved upwards by 31.9% to $3.35 during Friday's pre-market session. The company's market cap stands at $9.0 million. </li>
<li>LakeShore Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSB#NASDAQ">LSB</a>) stock moved upwards by 21.42% to $2.89. The market value of their outstanding shares is at $55.1 million. </li>
<li>OS Therapies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OSTX#AMEX">OSTX</a>) shares rose 12.3% to $2.19. The company's market cap stands at $46.5 million. </li>
<li>AquaBounty Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQB#NASDAQ">AQB</a>) stock rose 11.18% to $0.77. The market value of their outstanding shares is at $2.9 million. </li>
<li>Mainz Biomed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNZ#NASDAQ">MYNZ</a>) shares moved upwards by 9.52% to $5.85. The company's market cap stands at $12.9 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) stock increased by 9.32% to $0.9. The market value of their outstanding shares is at $15.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares fell 32.9% to $0.17 during Friday's pre-market session. The market value of their outstanding shares is at $2.3 million. </li>
<li>Kazia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZIA#NASDAQ">KZIA</a>) stock fell 11.58% to $1.68. The company's market cap stands at $9.3 million. </li>
<li>TruBridge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBRG#NASDAQ">TBRG</a>) shares decreased by 10.17% to $22.1. The company's market cap stands at $329.8 million. </li>
<li>Cytek Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTKB#NASDAQ">CTKB</a>) shares declined by 9.72% to $5.11. The company's market cap stands at $658.2 million. </li>
<li>Scienture Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNX#NASDAQ">SCNX</a>) stock fell 9.24% to $3.54. The market value of their outstanding shares is at $30.4 million. </li>
<li>Concord Medical Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) shares fell 8.76% to $5.0. The company's market cap stands at $217.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSGM

CTKB

KZIA

MYNZ

NIVF

OSTX

SCNX

TBRG

12 Health Care Stocks Moving In Friday's Pre-Market Session

Press Releases

ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.

Biotech

General

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences

Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor

Management

Former Merck USA President Joins Klotho Neurosciences' Board of Directors

Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences' Scientific Advisory Board

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

WENA

Comments

Klotho Neurosciences

Klotho Neurosciences (KLTO) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga